Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery

Journal of Neuro-Oncology

Volumn 108, Issue 2, 2012, Pages 327-332

  Talacchi, A ^a   D'Avella, D ^b   Denaro, L ^b   Santini, B ^a   Meneghelli, P ^a   Savazzi, S ^a   Gerosa, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Brain tumors; Clinical assessment; Cognitive assessment; Surgical treatment

Indexed keywords

AMINOLEVULINIC ACID;

ARTICLE; BRAIN CANCER; BRAIN METASTASIS; BRAIN SURGERY; BRAIN TUMOR; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; FLUORESCENCE; GLIOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRACTICE GUIDELINE; PROGNOSIS; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; TUMOR GROWTH; WELLBEING;

BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; GLIOMA; GUIDELINES AS TOPIC; HUMANS; NEUROSURGICAL PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS;

EID: 84864034382     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0818-3     Document Type: Article

References (57)

1. Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez JP, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulation. An anatomofunctional study. Brain 125:199-214 (Pubitemid 34084048)
2. Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulation in surgery of low-grade gliomas: a comparative study between two series without (1985-1996) and with (1996-2003) functional mapping in the same situation. J Neurol Neurosurg Psychiatry 76:845-851 (Pubitemid 40805817)
3. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30(Suppl 19):10-14 (Pubitemid 38199157)
4. Compostella A, Tosoni A, Blatt V, Franceschi E, Brandes AA (2007) Prognostic factors for anaplastic astrocytomas. J Neurooncol 81:295-303 (Pubitemid 46165334)
5. Karnofsky DA, Burcheral JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191-205
6. Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24:1305-1309 (Pubitemid 46622034)
7. Mauer ME, Bottomley A, Taphoorn MJ (2008) Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice. Curr Opin Neurol 21:745-753
8. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151-1161
9. Osoba D, Aaronson NK, Muller M et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139-150 (Pubitemid 26100512)
10. Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355-1363
11. Weitzner MA, Meyers CA, Byrne K (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 84:29-34 (Pubitemid 26006993)
12. Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18-27
13. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO et al (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175-1181 (Pubitemid 36617917)
14. Chang S, Vogelbaum M, Lang FF, Haines S, Kunwar S, Chiocca EA, Olivi A, Quinones-Hinojosa A, Parsa A, Warnick R (2007) GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of surgically based therapeutic clinical trials. J Neuroncol 82:211-220 (Pubitemid 46431868)
15. Taphoorn MJ, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolberg JG, Karim ABM (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55:372-376
16. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, Van Den Bent MJ, Mason W, Mirimanoff RO et al (2005) Health related quality of life in patients with glioblastoma: a randomised clinical trial. Lancet Oncol 6:937-944 (Pubitemid 41685226)
17. Giovagnoli AR, Boiardi A (1994) Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci 15:481-488
18. Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA et al (2001) A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92:420-433 (Pubitemid 32664450)
19. Liu R, Page M, Solheim K, Fox S, Chang SM (2009) Quality of life in adults with brain tumors: current knowledge and future directions. Neuro-oncology 11:330-339
20. Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562-568 (Pubitemid 40486584)
21. Pålson A, Ek L, Ahlström G, Smita A (2003) Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol 65:149-158 (Pubitemid 37521314)
22. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumors. Lancet Neurol 3:159-168 (Pubitemid 38229950)
23. World Health Organization (2001) International classification of functioning, disability, and health. World Health Organization, Geneva
24. Stummer W, Pichlmaier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392-401
25. Phillips C, Guiney M, Smith J, Hughes P, Narayan K, Quong G (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68:23-26 (Pubitemid 37289332)
26. Roa W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583-1588 (Pubitemid 41079795)
27. Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535 (Pubitemid 46588417)
28. Levin VA, Phuphanich S, Yung WK et al (2006) Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol 78:295-302 (Pubitemid 44018824)
29. Henriksson R, Malmstrom A, Bergstrom P et al (2006) Highgrade astrocytoma treated concomitantly with estramustine and radiotherapy. J Neurooncol 78:321-326 (Pubitemid 44018828)
30. Souhami L, Seiferheld W, Brachman D et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60:853-860 (Pubitemid 39311766)
31. Cheng J, Zhang X, Liu BL (2009) Health-related quality of life in patients with high-grade glioma. Neuro-oncology 11:41-50
32. Efficace F, Bottomley A (2002) Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 38:1824-1831 (Pubitemid 35247467)
33. Yung WK, Albright RE, Olson J et al (2000) A phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588-593 (Pubitemid 30636298)
34. Trojanowski T, Peszynski J, Turowski K et al (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 70:18-23
35. Pickles T, Goodman GB, Rheaume DE et al (1997) Pion radiation for high grade astrocytoma: results of a randomized study. Int J Radiat Oncol Biol Phys 37:491-497 (Pubitemid 27175300)
36. Bampoe J, Laperriere N, Pintilie M, Glen J, Micallef J, Bernstein M (2000) Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg 93:917-926 (Pubitemid 32800600)
37. Kiebert GM, Curran D, Aaronson NK et al (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34:1902-1909 (Pubitemid 28535439)
38. Mintz A, Perry J, Spithoff K, Chambers A, Lapierre N (2007) Management of single brain metastasis: a practice guideline. Curr Oncol 14:131-143
39. Signorelli F, Guyotat J, Isnard J, Schneider F, Mohammedi R, Bret P (2001) The value of cortical stimulation applied to the surgery of malignant gliomas in language areas. Neurol Sci 22:3-10 (Pubitemid 33622075)
40. Fb Meyer, Bates LM, Goerss SJ, Friedman JA, Windschitl WL, Duffy JR, Perkins WJ, O'Neill BP (2001) Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76:677-687 (Pubitemid 32595419)
41. Haglund MM, Berger MS, Shamseldin M, Lettich E, Ojemann GA (1994) Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 34:567-576 (Pubitemid 24100522)
42. Bello L, Gallucci M, Fava M, Carrabba G, Giussani C, Acerbi F, Baratta P, Songa V et al (2007) Intraoperative subcortical language tract mapping guides surgical removal for gliomas involving speech areas. Neurosurgery 60:67-80 (Pubitemid 46102916)
43. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L, Lopes M, Mitchell MC et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98:764-778 (Pubitemid 36396778)
44. Medical Research Council (1981) Aids to the examination of the peripheral nervous system. Memorandum no. 45. Her Majesty's Stationery Office, London
45. House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146-147 (Pubitemid 15064413)
46. Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55-66 (Pubitemid 18067482)
47. Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed highgrade glioma patients. J Clin Oncol 19:4037-4047 (Pubitemid 32976690)
48. Brown PD, Maurer MJ, Rummans TA et al (2005) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495-504
49. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361-1368 (Pubitemid 35341299)
50. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr (2004) Depression in patients with high-grade glioma: results of the Glioma Outcome Project. Neurosurgery 54:358-367 (Pubitemid 38209404)
51. Costello A, Shallice T, Gullan R, Beaney R (2004) The early effects of radiotherapy on intellectual and cognitive functioning in patients with frontal brain tumors: the use of a new neuropsychological methodology. J Neurooncol 67:351-359 (Pubitemid 39137367)
52. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992-999 (Pubitemid 36287002)
53. Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 14:1205-1212 (Pubitemid 44800639)
54. Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324-333 (Pubitemid 32049338)
55. Talacchi A, Santini B, Savazzi S, Gerosa M (2010) Cognitive effect of tumor and surgical treatment in glioma patients. J Neuroncol 103:541-549
56. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg- Johnsen J, Storm-Mathisen I, Hirschberg H (1997) Survival, prognostic factors and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129-3140 (Pubitemid 27377505)
57. Olson JD, Riedel E, DeAngelis L (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442-1448. (Pubitemid 30210463)